SIO GENE THERAPIES

Welcome to the Brand page for “SIO GENE THERAPIES”, which is offered here for The mark consists of the stylized letters sio above the words gene therapies with a design of a double helix integrated within the o in sio.;pharmaceutical preparations for human use used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments; biologic preparations for medical and therapeutic purposes used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments;providing health and medical information; providing medical and health information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; all of the foregoing used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and antiaging and anti-wrinkle skin care prevention preparations and treatments;gene therapies;scientific and technological services and research and design relating thereto in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical, biomedical and biological therapeutic research services in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical research and development in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; all of the foregoing excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments;.

Its status is currently believed to be active. Its class is unavailable. “SIO GENE THERAPIES” is believed to be currently owned by “Sio Gene Therapies Inc.”

Owner:
SIO GENE THERAPIES INC.
Owner Details
Description:
The mark consists of the stylized letters SIO above the words GENE THERAPIES with a design of a double helix integrated within the O in SIO.;Pharmaceutical preparations for human use used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments; biologic preparations for medical and therapeutic purposes used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments;Providing health and medical information; providing medical and health information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; all of the foregoing used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and antiaging and anti-wrinkle skin care prevention preparations and treatments;GENE THERAPIES;Scientific and technological services and research and design relating thereto in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical, biomedical and biological therapeutic research services in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical research and development in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; all of the foregoing excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments;
Categories: